Search research articles
Contact Us
Filters
Showing results (151-160 of 225) with videos related to
Page
of 23
Sort By:
Clinical and Translational Radiation Oncology
|
March 5, 2024
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study
Kobika Sritharan, Lois Daamen, Angela Pathmanathan, et al.
British Journal of Cancer
|
April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity
Mahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Frontiers in Oncology
|
August 15, 2020
Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials
Marco Marcello, James W Denham, Angel Kennedy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2020
Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials
Marco Marcello, James W Denham, Angel Kennedy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2020
Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials
Marco Marcello, James W Denham, Angel Kennedy, et al.
BJU International
|
March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer
A Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.
Radiology
|
October 2, 2019
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker
Jessica M Winfield, Jennifer C Wakefield, David Dolling, et al.
Biomolecules
|
April 30, 2025
Effects of Testosterone and Its Major Metabolites upon Different Stages of Neuron Survival in the Dentate Gyrus of Male Rats
Mark D Spritzer, Ethan A Roy, Kelsey M K Calhoun, et al.
European Urology
|
March 4, 2018
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)
Niven Mehra, David Dolling, Semini Sumanasuriya, et al.
The Lancet. Oncology
|
December 16, 2011
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial
David Dearnaley, Isabel Syndikus, Georges Sumo, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 225) with videos related to
Sort By:
Page
of 23
Clinical and Translational Radiation Oncology
|
March 5, 2024
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study
Kobika Sritharan, Lois Daamen, Angela Pathmanathan, et al.
British Journal of Cancer
|
April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity
Mahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Frontiers in Oncology
|
August 15, 2020
Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials
Marco Marcello, James W Denham, Angel Kennedy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2020
Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials
Marco Marcello, James W Denham, Angel Kennedy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2020
Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials
Marco Marcello, James W Denham, Angel Kennedy, et al.
BJU International
|
March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer
A Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.
Radiology
|
October 2, 2019
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker
Jessica M Winfield, Jennifer C Wakefield, David Dolling, et al.
Biomolecules
|
April 30, 2025
Effects of Testosterone and Its Major Metabolites upon Different Stages of Neuron Survival in the Dentate Gyrus of Male Rats
Mark D Spritzer, Ethan A Roy, Kelsey M K Calhoun, et al.
European Urology
|
March 4, 2018
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)
Niven Mehra, David Dolling, Semini Sumanasuriya, et al.
The Lancet. Oncology
|
December 16, 2011
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial
David Dearnaley, Isabel Syndikus, Georges Sumo, et al.
Page
of 23